Cetera Investment Advisers’s Corcept Therapeutics CORT Stock Holding History

Cetera Investment Advisers’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	+11,668	New	+$705K	﹤0.01%	3049
2026 Q1	–	Sell	-7,895	Closed	-$275K	–	4839
2025 Q4	$275K	Sell	7,895 -8,199	-51%	-$644K	﹤0.01%	3977
2025 Q3	$1.34M	Buy	16,094 +4,965	+45%	+$359K	﹤0.01%	2524
2025 Q2	$817K	Buy	11,129 +2,755	+33%	+$200K	﹤0.01%	2559
2025 Q1	$956K	Sell	8,374 -13,674	-62%	-$832K	﹤0.01%	2290
2024 Q4	$1.11M	Sell	22,048 -5,043	-19%	-$264K	﹤0.01%	2099
2024 Q3	$1.25M	Sell	27,091 -11,201	-29%	-$398K	﹤0.01%	1957
2024 Q2	$1.24M	Buy	38,292 +2,244	+6%	+$61.5K	﹤0.01%	1917
2024 Q1	$908K	Buy	+36,048	New	+$852K	﹤0.01%	2154

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Investment Advisers's CORT Position: Q2 2026 in Review

Cetera Investment Advisers opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 11,668 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #3049 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in CORT as recently as Q4 2025.

Cetera Investment Advisers first reported a position in CORT in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.34M in Q3 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Cetera Investment Advisers held 11,668 shares of Corcept Therapeutics worth $1.01M as of Q2 2026.
Corcept Therapeutics was a new Cetera Investment Advisers position in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3049 holding.
Cetera Investment Advisers first reported a position in Corcept Therapeutics in Q1 2024 and has held it in 9 quarters since.
Cetera Investment Advisers's Corcept Therapeutics position peaked at $1.34M in Q3 2025.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.